Clinical and Economic Impact of an Electronic Medical Record Interfaced Decision Support System for Minimizing Severe Drug-Drug Interactions

Leumit Health Services, an health maintenance organization operating in Israel, will incorporate a web-based, decision support system for handling drug-drug interactions and drug information, termed DDI+. the investigators hypothesize that implementing such a system will reduce health-care expenditures (e.g., hospital admissions, referrals to ERs, Imaging procedures).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthcare

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Leumit Health Services

Tel Aviv, Israel

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Number of chronic concomitant drugs ≥5

Exclusion criteria

Patients diagnosed with HIV/AIDS, and/or viral hepatitis B or C.

Treatment and study plan

DDI+

Other

Primary outcomes

Hospital Admissions

Time frame: up to 12 months post initiation

Sponsors and collaborators

Lead sponsor

Leumit Health Services

Other

Registry information

Acronym: DDI+

Important dates

Study start: 2013
Primary completion: 2014
Study completion: 2014
First posted: Jan 10, 2013
Registry last updated: Oct 21, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed